Boswellia carterii extract
CAS 89957-98-2
Boswellia carterii extract (CAS 89957-98-2) is a pharmaceutical compound with 0 bioactivity targets and 53 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Boswellia carterii extract is linked to DTXSID801018963 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Boswellia carterii extract used for in pharmaceutical contexts?
Boswellia carterii extract (CAS 89957-98-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Boswellia carterii extract?
Boswellia carterii extract has 53 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Adverse drug reaction, Affective disorder, Alopecia, Amnesia, Anxiety. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Boswellia carterii extract also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Serenoa Serrulata Fruit Extract with EU status "permitted".
What clinical phase is Boswellia carterii extract in?
No phase 1-4 clinical development badge is rendered for Boswellia carterii extract because the matched compound identifier rows do not contain a max-phase value.